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Background: Childhood-to-adult persistent asthma is usually considered to be an atopic disease. However
gastroesophageal reflux may also play an important role in this phenotype of asthma, especially when it is
refractory to pulmonary medicine.
Methods: Fifty-seven consecutive GERD patients who had decades of childhood-to-adult persistent asthmatic
symptoms refractory to pulmonary medication were enrolled. GERD was assessed by a symptom questionnaire,
endoscopy, reflux monitoring, and manometry, and treated by Stretta radiofrequency (SRF) or laparoscopic Nissen
fundoplication (LNF). The outcomes were followed up with a questionnaire for an average of 3.3 ± 1.1 years.
Results: Upper esophageal sphincter hypotonia, lower esophageal sphincter (LES) hypotonia, shortened LES, and
esophageal body dyskinesia were demonstrated by esophagus manometry in 50.9%, 43.9%, 35.1%, and 45.6% of
the patients, respectively. The symptom scores for heartburn, regurgitation, coughing, wheezing, and chest
tightness significantly decreased from 5.8 ± 2.0, 5.6 ± 2.0, 7.3 ± 1.6, 8.4 ± 1.2, and 8.1 ± 1.5, to 1.2 ± 1.8, 1.1 ± 1.6,
2.8 ± 2.5, 3.8 ± 2.7, and 3.9 ± 2.7, respectively, after anti-reflux treatment (P < 0.001).
Conclusions: Esophagus dysfunction is high in childhood-to-adult persistent asthmatic patients with GERD. SRF
and LNF are both effective for esophagus symptoms as well as persistent asthmatic symptoms for these patients.
GER may relate with asthmatic symptoms in some patients. Evaluating asthmatic patients for possible treatment of
the underlying cause, such as GERD, may improve symptoms and prevent disease persistence.
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Asthma is one of the most common chronic illnesses in
children. In the USA, national estimates of current asthma
prevalence among the children in selected minority
subgroups range from 4.4% in Asian Indian children to
13.0% in American Indian/Alaska Native children [1]. In
longitudinal cohort studies, 17%–49% of young children
have wheezing with different pediatric asthma phenotypes,
of which 4%–14% is a persistent wheeze [2]. Sears et al. re-
peatedly investigated asthmatic children from 9 to 26 years
of age with questionnaires and found that 14.5% had
wheezing that persisted from childhood to 26 years of age* Correspondence: zhonggaowang@126.com
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unless otherwise stated.and 12.4% subsequently relapsed by the age of 26. The
factors predicting persistence or relapse were sensitization
to house dust mites, airway hyper-responsiveness, female
sex, smoking, and early age at onset [3]. Recently, consid-
ering asthma as a multi-factorial disease related to familial
and environmental influences has become a consensus.
The risk factors include family history of asthma, personal
history of atopic dermatitis (skin allergies), or allergic
rhinitis (such as hay fever) and exposure to air pollutants,
especially cigarette smoke [4]. Gastroesophageal reflux
disease (GERD) is a common disorder in children that
may play an important role in childhood asthma. Although
an investigation into a potential association between child-
hood asthma and GER has not been performed, there are
many articles reporting this association in pediatric patients
[5]. However, due to methodological limitations of existingThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Hu et al. Annals of Surgical Innovation and Research 2014, 8:3 Page 2 of 7
http://www.asir-journal.com/content/8/1/3studies, the paucity of population-based studies, and a lack
of longitudinal studies, several aspects of relationship
between GER and asthma in children remain unclear
[6]. We have been focusing on treating GERD related
respiratory symptoms for 8 years, [7,8] and our fundamen-
tal concern is that reflux is a risk factor for recurrent
microaspiration, which may play an important role in child-
hood asthma, including its persistence [9,10]. Therefore,
the present study assessed childhood-to-adult persistent
asthma with respect to GERD evaluation and active anti-
reflux intervention effects in order to evaluate a possible
relationship between GER with this asthma phenotype.
Methods
Clinical data were gathered in a retrospective manner
with the approval of the Ethics Committee of The Second
Artillery General Hospital. Written informed consent for
participation in the study was obtained from all patients.
The patients enrolled in this study met the following
criteria: (1) GERD evaluation treated by Stretta radio-
frequency (SRF) or laparoscopic Nissen fundoplication
(LNF) as described in our previous studies at Center
for GERD, The Second Artillery General Hospital PLA,
Beijing Normal University, People’s Republic of China;
[11,12] (2) >18 years of age; (3) persistent episodic attacks
of wheezing and asthma since childhood (1 to 18 years of
age), which were identified and diagnosed by physicians in
other hospitals for more than 10 years before admission;
and (4) had little or insufficient response to long-term and
full dose medication for asthmatic symptoms.
Evaluation of lung function and GER
Basal lung function tests were conducted on admission.
The presence of acid GER was tested by ambulatory
24-hour dual pH monitoring, and a De Meester (DMS)
score of >14.72 was considered to be positive for in-
creased acid GERD (sensitivity, 96%; specificity, 96%);
[13] endoscopic evaluations for hiatus hernia (HH) and
esophagitis according to Los Angeles (LA) classification;
and esophagus manometry for elucidating hypotonia of
the upper esophageal sphincter (UES) and lower esopha-
geal sphincter (LES), length of LES, and esophageal body
dyskinesia were all assessed.
Questionnaire to investigate the symptoms and medication
at admission and in the follow-up after SRF or LNF
Questionnaires were completed before the SRF and LNF
treatment and then for the follow-up. A 6-point scale
ranging from 0 to 5 was applied to assess the severity
and frequency of heartburn, regurgitation, coughing,
wheezing, and chest tightness according to the Reflux
Diagnostic Questionnaire as was applied in our previous
studies [14-16]. Medications used for asthmatic symptoms,
such as aminophylline, inhaled corticosteroids, inhaledbeta-agonists, and oral corticosteroids, amongst others,
were documented. Degree of satisfaction (very satisfied,
satisfied, acceptable, dissatisfied, and very dissatisfied)
toward anti-reflux treatment for asthmatic symptom was
investigated at the follow-up.
The outcomes of anti-reflux treatment for asthmatic
symptoms were as follows:
(1)Cure: asymptomatic without medication;
(2)Excellent: only occasionally mild, slight, or no
asthmatic symptoms. Anti-asthma medication is
completely ceased or reduced by more than half;
(3)Good: less than weekly attacks of mild to moderate
wheezing. Anti-asthma medication is still in use with
various reductions;
(4)Fair: the severity or frequency score is only
decreased by one or two points. The patient still has
weekly severe or moderate asthmatic symptoms.
Drug consumption reduced by less than half or
unchanged;
(5)Poor: asthmatic symptoms and drug consumption is
unchanged.
Statistical analysis
Data analysis was performed using SPSS version 13
software (SPSS Inc., Chicago, IL, USA). Comparisons
of mean values of the studied parameters before and after
treatment were performed using the paired Student’s
t-test. Comparisons of the magnitude of change for
the continuous variables between different groups were
carried out using Mann–Whitney U-test. Correlations of
non-normal variables were assessed using Spearman rank
correlation coefficients. All P-values less than 0.05 were
considered statistically significant.
Results
This study investigated consecutive asthmatic cases
enrolled at our center for GERD from December 2007
to April 2011. In total, 57 cases fulfilled our inclusion
criteria and were followed up in January 2013. Among
these cases, SRF was carried out in 24 and LNF was
performed in 33, with two of the latter having previously
received SRF therapy. The mean follow-up duration was
3.3 ± 1.1 years (range 2–6 years). Patient demographics
and baseline pulmonary and GER evaluation are sum-
marized in Table 1. The DMS of distal esophagi is more
intensive than that of proximal esophagi (P < 0.001) and
they are correlated (r = 0.268, P = 0.018). Patients with
HH had higher heartburn score (P = 0.036) and weaker
LES (P = 0.008).
The length of stay after anti-reflux intervention ranged
from 2 to 7 days for LNF with a median of 4.0 days, and
from 2 to 6 days for SRF with a median of 3.2 days. By
the end of an average of 3.3 years of follow-up, the
Table 1 Patient demographics, baseline pulmonary, and
GER evaluation
Variables Total (n = 57)
Sex, M/F 18/39
Age (range), years 47.3 ± 13.3 (20–81)
Smoker/nonsmoker 4/53
Wheezing onset age (range), years 10.2 ± 4.5 (1–16)
Duration of wheezing (range), years 38.1 ± 12.7 (10–70)
Lung function test
FVC, L (% predicted) 3.1 ± 0.9 (93.2 ± 20.6%)
FEV1, L (% predicted) 1.67 ± 0.7 (62.8 ± 21.8%)
FEF, L/sec (% predicted) 4.5 ± 2.2 (66.9 ± 26.3%)
FEV1/FVC 54.6 ± 14.9%
FEV1/FVC < 70%, 30%–49%, < 30% 17 (29.8%), 13 (22.8%), 1 (1.8%)
Blood eosinophil count, cells/mm3
(P%)
305.2 ± 325.3 (17.5%)
Esophageal endoscopy
Esophagitis (P%) 27 (47.4%)
LA-A, LA-B, LA-C, LA-D 14, 10, 2, 1
Barrett esophagus (P%) 1 (1.8%)
Hiatal hernia (P%) 20 (35.1%)
Dual 24 hour pH monitoring
Distal channel DMS (P%) 41.94 ± 59.11 (64.9%)
Proximal channel DMS (rang) 8.12 ± 10.23 (0.20 - 50.77)
High-resolution manometry
MUESP, mmHg (P%) 41.2 ± 22.7 (50.9%)
MLESP, mmHg (P%) 14.2 ± 6.9 (43.9%)
LHPZ, cm (P%) 2.9 ± 0.7 (35.1%)
Esophageal dyskinesia 26 (45.6%)
LA, Los Angeles classification; DMS, DeMeester score; MUESP, mean upper
esophageal sphincter pressure (Normal range: 34–104 mmHg); MLESP, mean
lower esophageal sphincter pressure (Normal range: 13–43 mmHg); LHPZ,
length of high pressure zone (Normal range: 2.7–4.8 cm); P%: percentage of
positive finding.
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wheezing, and chest tightness significantly decreased
from 5.8 ± 2.0, 5.6 ± 2.0, 7.3 ± 1.6, 8.4 ± 1.2, and 8.1 ± 1.5
to 1.2 ± 1.8, 1.1 ± 1.6, 2.8 ± 2.5, 3.8 ± 2.7, and 3.9 ± 2.7
respectively, with reduction rates of 75.1% ± 35.9%,
75.3% ± 35.8%, 58.4% ± 34.9%, 53.9% ± 32.4%, and 51.9% ±
32.7%, respectively (P < 0.001; Table 2). Cure, excellent,
and good outcome for overall asthma status were obtained
in 7.0%, 31.6%, and 26.3% of the patients, respectively,
while 21.1% and 14.0% of the patients had fair and
poor response to the anti-reflux treatment, respect-
ively (Figure 1). The two patients previously treated by
SRF without a satisfactory response later accepted
LNF, and one of them was cured and the other had an
excellent outcome. In 34 patients who had frequent or
daily nocturnal awakening, cough, and wheezing beforeanti-reflux treatment, 11 (32.4%) patients resumed normal
sleeping, while 14 (41.2%) patients markedly improved
and their nocturnal episodes became occasional.
Moreover, 28.1% of the patients reported that their
asthmatic symptoms were getting better, 49.1% of the
patients were stable, and 22.8% of the patients responded
well to the anti-reflux treatment for 6 months to 2 years
before they experienced various degrees of recurrence
(Table 3).
In total, 21.1% of patients felt very satisfied and 43.9%
felt satisfied about the outcome of their anti-reflux treat-
ment, while 26.3%, 7%, and 1.8% felt acceptable, dissatisfied,
and very dissatisfied, respectively (Table 4).
Esophagus symptom scores had significantly greater
reductions than asthmatic symptoms (P < 0.001; Figure 2A).
Compared to SRF, the LNF outcomes were significantly
better with respect to esophagus symptoms (P = 0.002), but
not significant better for asthmatic symptoms (P = 0.387;
Figure 2B). The reduction rate in asthmatic symptom
score was significantly correlated with esophagus symptom
(rs = 0.509, P < 0.001).
No major complications or deaths occurred during our
study. Among patients receiving SRF treatment, some pa-
tients experienced several short term complications which
disappeared within 1 week, such as throat discomfort in
four cases, retrosternal discomfort in six cases, transient
nausea/vomiting in three cases, and short-term dysphagia
in three cases. As for patients receiving LNF, seven cases
had mild dysphagia: three recovered within 1 month; four
still had occasional symptoms when eating quickly or solid
foods; three cases had prolonged bloating and two cases
had increased passage of gas by anus; and three cases had
reduced appetite.
Discussion
The association between asthma and GER has been de-
bated for decades after Sir William Osler first observed
the association between worsening asthma and distended
stomachs in 1892 [17]. The frequency of GER in asthmatic
children was higher than its frequency in other children,
which serves as important evidence that asthma and GER
are closely related. Historically, the prevalence of GERD in
children with asthma ranges from 19.3% to 80.0% with an
average of 22.8%. The average rate of abnormal esophageal
pH is 68.2% and esophagitis is 35.6% [6] and aspiration of
gastric contents in the respiratory tree is not rare in pa-
tients with GERD [18]. Theoretically, GER and asthmatic
symptoms may be connected through different mecha-
nisms, including micro-aspiration, and both local and cen-
tral reflexes. In our study, dual pH monitoring identified
64.9% of patients with pathological acid reflux; esophagus
endoscopy showed 47.4% of patients had esophagitis.
Our study also found a high prevalence of disorders that
may increase GER by endoscopy and HRM. For instance,
Table 2 Outcome of anti-reflux therapy over 3.3 ± 1.1 years with respect to esophagus and asthmatic symptoms
Symptom Number of
patents (percent)




Regurgitation 50 (87.7%) 5.8 ± 2.0 1.2 ± 1.8 75.1 ± 35.9 <0.001
Heartburn 49 (86.0%) 5.6 ± 2.0 1.1 ± 1.6 75.3 ± 35.8 <0.001
Esophagus symptom 50 (87.7%) 11.3 ± 4.0 2.3 ± 3.2 75.5 ± 35.6 <0.001
Cough 46 (80.7%) 7.3 ± 1.6 2.8 ± 2.5 58.4 ± 34.9 <0.001
wheezing 57 (100%) 8.4 ± 1.2 3.8 ± 2.7 53.9 ± 32.4 <0.001
Chest tightness 55 (96.5%) 8.1 ± 1.5 3.9 ± 2.7 51.9 ± 32.7 <0.001
Asthmatic symptom 57 (100%) 22.1 ± 5.0 9.9 ± 7.2 54.3 ± 31.9 <0.001
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thermore, UES hypotonia, LES hypotonia, shortened LES,
and esophageal body dyskinesia were demonstrated by
esophagus manometry in 50.9%, 43.9%, 35.1%, and 45.6%
of the patients, respectively (Table 1). Although neither
HH nor weakened LES showed significantly higher DMS
in this study, HH or LES hypotonia often predicts a higher
risk of GERD due to its negative impact on esophagus
[19,20]. Although 24 hour pH-monitoring is one of the
current reference-standard methods for GER assessment
in children, it only detects acid reflux. A multichannel
intraluminal impedance and pH (MII-pH) monitoring,
which detect anterograde or retrograde acid or non-acid
bolus and determine the composition, might be more sen-
sitive for GER [21]. These aforementioned modalities may
have important diagnostic and therapeutic implications
for children or adults with difficult to control or consistent
asthmatic symptom. Recently, Negro et al. reported that
esophageal acidification has a good level of both sensitivity
and specificity by enhancing the Methacholine response
in forced expiratory volume in 1 second (FEV1) only inFigure 1 Overall clinical response of asthmatic symptoms to
anti-reflux therapy. By the end of an average of 3.3 year follow-up,
cure, excellent, good, fair, and poor outcomes in the overall asthma
status were obtained in 7.0%, 31.6%, 26.3%, 21.1%, and 14.0% of the
patients, respectively.the presence of acid GERD. This test could be a potentially
useful tool for better selection of GER-related asthma in
clinical practice [22].
Nearly 50% of children have wheezing with respiratory
illnesses in their first year of life, and 20% will have
continued wheezing in later childhood, which predicts
a probability of asthma [23]. The natural history of
GER in humans may provide clues to this phenomenon.
For instance, in the first 3 months of life, postprandial
reflux is considered a physiological event that gradually
decreases and disappears by 1 year of age [24]. The pro-
gressive decrease in episodes is due to maturation of the
LES and acquisition of sitting and standing. However,
some children have persistent regurgitation or reflux after
the age of one; their reflux is not only associated with
feeding, backwardness, irritability, unjustified crying,
sudden waking, persistent esophageal hiatus defect,
and esophagus malfunction, but also with the strenu-
ous asthmatic symptoms [25,26].
GER-related cough is defined as a cough that is im-
proved or resolved by GER therapy, thus analogically
GER-related asthmatic could also be defined by anti-reflux
outcome. Our fundamental concern for GER-related asth-
matic patients is that reflux is a risk factor for recurrent
microaspiration and irritation; therefore, effective GER
control is essential for the management of GER-related
respiratory symptoms [9]. Anti-acid therapies, such as
proton pump inhibitors (PPI), have been tested in ran-
domized trials for asthmatic children and adults and the
results revealed that PPI has no clear benefit on asthma
control compared to placebo [27,28]. Furthermore, surgi-
cal therapies in different uncontrolled series of childrenTable 3 Evolvement of patient clinical state during
follow up
SRF (n = 24) LNF (n = 33) Total (n = 57)
Improving 5 (20.8%) 11 (33.3%) 16 (28.1%)
Stable 13 (54.2%) 15 (45.5%) 28 (49.1%)
Partial recurrence 3 (12.5%) 3 (9.1%) 6 (10.5%)
Complete recurrence 3 (12.5%) 4 (12.1%) 7 (12.3%)
Table 4 Satisfactory evaluation of patients with anti-reflux
treatment for asthmatic symptoms
SRF (n = 24) LNF (n = 33) Total (n = 57)
Very satisfied 5 (20.8%) 7 (21.2%) 12(21.1%)
Satisfied 8 (33.3%) 17 (51.5%) 25 (43.9%)
Acceptable 7 (29.2%) 8 (24.2%) 15 (26.3%)
Dissatisfied 3 (12.5%) 1(3%) 4 (7%)
Very dissatisfied 1 (4.2%) 0 (0%) 1 (1.8%)
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and most of the selected patients experienced various
responses [29-31]. Studies of the outcomes of surgical
treatment may be less valuable in evidence based medi-
cine as they suffer from a lack of controls and blinding,Figure 2 Effect of anti-reflux treatment on the mean esophagus
symptom score and asthmatic symptom score. A: Esophagus
symptom score had significantly better reduction rate than
asthmatic symptoms. B: The outcome of LNF was significantly
better than SRF for esophagus symptoms, but the outcomes of
asthmatic symptoms between LNF and SRF groups showed no
significant difference. **P < 0.005.use different postoperative evaluation criteria, and are
typically based on a highly selective group of patients.
However, in our opinion, restoring the anatomical barrier
of gastroesophageal junction, by SRF or LNF, reduces the
volume, frequency, duration, and/or destination of GER
so that the related aspiration and irritation resolution may
be superior to medication therapy, such as PPI which
mainly reduces the acidity of GER and is of high recur-
rence when off medication. Thus, surgery may have better
value in the management of reflux-related respiratory
symptoms as presented in this study and previous LNF
and SRF studies [11,12,14,32].
As shown in the present study, 64.9% of the patients
had good or better response to SRF or LNF therapy, while
35.1% of the patients still had less than good outcomes
and 22.8% of the patients experienced different degrees of
recurrence. This data suggests that the anti-reflux therapy
at hand is not a panacea in these selected asthmatics as a
whole. It is still difficult to define whether an a priori sub-
set of asthmatics will improve with anti-reflux therapy.
Complications, such as mild dysphagia and bloating, were
evident in patients after receiving LNF; for instance, five
of the seven dysphagia patents and two of the three bloat-
ing patients were found to have esophageal dyskinesia by
esophagus manometry, which indicates that pre-LNF
esophageal dyskinesia may represent a risk factor for com-
plications after LNF. In this study, we showed that the
outcome of asthmatic symptoms is highly related to the
effectiveness of anti-reflux therapy and that their symptom
scores are significantly correlated. The two patients who
failed on SRF treatment in this study still had a second
chance to attain a successful outcome when effective LNF
is applied. Therefore, effective GER control is one of the
key factors for successful GER-related asthmatic manage-
ment. Although SRF treatment is less effective for esopha-
gus symptoms, it is relatively less invasive with fewer
complications. Furthermore, there has not been a perfect
anti-reflux approach that can completely bring GER under
control while avoiding complications and recurrence.
Thus, it is still valuable to offer re-intervention for patients
who failed on primary anti-reflux treatment.
Another key element for GER-related asthma is persistent
airway hyperactivity. In the present study, although remark-
able outcomes were obtained after effective GFR control,
the majority of patients still reported exacerbations of asth-
matic symptoms, which could be triggered by catching a
cold, exertion, and/or strong odors, such as cigarette smoke
and petrol fumes. Therefore, systemic corticosteroids were
discontinued after SRF or LNF, while other anti-asthma
medications, such as inhaled corticosteroids, inhaled beta-
agonists, and/or aminophylline with reduced dosage, were
still maintained in most patients.
Although the majority of asthma patients may obtain
the targeted level of control with pulmonary medication,
Hu et al. Annals of Surgical Innovation and Research 2014, 8:3 Page 6 of 7
http://www.asir-journal.com/content/8/1/3some patients will not achieve control even with the best
therapy, [33] a group which probably accounts for less
than 5% of all children with asthma. The management of
this group of children is complex, with little evidence
to guide the choice of further treatment for those who
remain symptomatic even after the use of regular systemic
corticosteroids. The lives of children with difficult to treat
asthma are severely disrupted with frequent hospital visits,
school absence, and limitations in normal activities. Be-
havioral problems and a lower quality of life are more
pronounced in those children [34]. However, a review
by Mutius et al. [35] indicates that over the past two
centuries real progress has been made in asthma research.
Allergic responses that often substantially contribute to
both chronic persistent asthma and acute exacerbations of
asthma symptoms have been extensively studied and may
be overemphasized. The precise nature of this inflamma-
tion remains a mystery, the fundamental causes of asthma
are still not understood, and asthma still has no cure. The
medications at hand provide symptomatic relief and
improve lung function and airway responsiveness, but
they do not prevent exacerbations or disease progression.
However, studying active anti-reflux in GER-related asth-
matics may partly provide alternative insights into mecha-
nisms and management of this disorder.
Conclusions
Esophagus related mortality is high in childhood-to-adult
persistent asthmatic patients with GERD. SRF and LNF are
both effective for treating esophagus symptoms as well as
GERD-related persistent asthmatic symptoms. GER may
also play an important role in this asthma phenotype. The
evaluation of patients for possible treatment of the under-
lying causes of asthma, such as GER, can improve symp-
toms and prevent disease persistence. However, large-scale
and controlled studies are further indicated.
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